COVID-19-associated encephalitis successfully treated with combination therapy

COVID-19-associated encephalitis successfully treated with combination therapy

Background: Acute encephalitis can occur in different viral diseases due to infection of the brain or by an immune mechanism. Severe novel coronavirus disease 2019 (COVID-19) is associated with a major immune inflammatory response with cytokine upregulation including interleukin 6 (IL-6). We report...

Full description

Bibliographic Details
Main Authors: Eric Freire-Álvarez, Lucía Guillén, Karine Lambert, Ana Baidez, Miguel García-Quesada, María Andreo, Jordi Alom, Mar Masiá, Félix Gutiérrez
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Clinical Infection in Practice
Subjects:
Encephalitis
COVID-19
SARS-CoV-2
Acute demyelinating encephalomyelitis
Tocilizumab
Immunoglobulins
Online Access:http://www.sciencedirect.com/science/article/pii/S2590170220300406

Internet

http://www.sciencedirect.com/science/article/pii/S2590170220300406

Similar Items